![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhengzhou Minzhong Pharmaceutical Co., Ltd. Zhengzhou City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Rifampicin, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2004-295 - Rev 00
This Chemical Type CEP, issued on December 16, 2008, remains in force until January 23, 2013, ensuring its reliability within the pharmaceutical industry.
Substance Number 52 associated with this CEP further emphasizes